This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Corbus Pharmaceuticals Holdings' financial position is stable for now, with about two years of cash runway. Click here to ...

Objective Tumour-associated macrophages (TAMs) and their alternative activation contribute greatly to the development of hepatocellular carcinoma (HCC). Tim-3 is highly expressed on macrophages and ...

Follistatin-344 peptide has garnered significant attention in scientific research due to its intricate interactions with ...

Follistatin-344 (FS-344), a glycoprotein variant, has emerged as a focal point in scientific research due to its potential ...

Effects of stimulation with transforming growth factor-beta (TGF-β) for various times on the expression of phosphorylated Smad3 and Smad7 in hepatic stem-like cells determined by immunoblot. For ...

Concludes Strategic Alternatives Review and Provides Update on Development of KER-065LEXINGTON, Mass., June 09, 2025 (GLOBE ...

Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with ...

There is some evidence that transforming growth factor-beta ( TGF-β) can influence cellular behaviors. Similarly, PEF was found to modulate the activity of cells. However, the combined effect of PEF ...

TGF-beta signaling also controls vascular development, with loss-of-function mutations in TGF-beta receptor 1 (TGFBR1/ALK5), TGFBR2, the EC accessory receptor Endoglin, or various SMADs producing ...

Endothelial cell-specific loss of TGF-beta signaling in mice leads to CNS vascular defects, specifically impairing retinal development and promoting immune cell infiltration. The data are solid, ...